Relevance of second messengers in cystic fibrosis.
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000242:Cyclic AMP / Q000378:metabolism*; D003550:Cystic Fibrosis / Q000378:metabolism* / Q000503:physiopathology; D005347:Fibroblasts / Q000378:metabolism; D006801:Humans; D007545:Isoproterenol / Q000494:pharmacology*; D018377:Neurotransmitter Agents / Q000502:physiology; D011458:Prostaglandins E / Q000502:physiology; D011941:Receptors, Adrenergic; D011943:Receptors, Adrenergic, beta
D000319:Adrenergic beta-Antagonists; D018377:Neurotransmitter Agents; D011458:Prostaglandins E; D011941:Receptors, Adrenergic; D011943:Receptors, Adrenergic, beta; D000242:Cyclic AMP; D007545:Isoproterenol